Ipamorelin 10mg — Research Grade Peptide

Name: Ipamorelin 10mg
Brand: Volta Peptides
SKU: vp-009
Price: 49.00 USD
Availability: InStock

Research Use Only

13 sold this week9 people viewing this

$49 USD

Ordering above $1,000?Wholesale pricing →

All orders dispatched within 24hrs

Application formLyophilized powder

StorageRefrigerated

Purity98%

Weight10mg

CAS Number170851-70-4

Research Use Only

For in vitro laboratory research by qualified professionals only. Not for human or animal administration. Not intended to treat, prevent, mitigate, or cure any disease. Batch-specific Certificates of Analysis available for all products.

Ipamorelin is a selective growth hormone secretagogue (GHS) pentapeptide that stimulates GH release without significantly affecting cortisol or prolactin levels. Widely used in research investigating targeted GH-axis modulation.

Related Research News

Regulatory

CJC-1295 with DAC and Ipamorelin: Growth Hormone Research Guide

CJC-1295 with DAC and Ipamorelin represent key compounds in growth hormone research, targeting distinct pathways for GH and IGF-1 signaling. CJC-1295 with DAC acts as a long-acting GHRH analogue with a half-life of 5.8 to 8.1 days, while Ipamorelin functions as a selective growth hormone secretagogue via the ghrelin receptor. Together, they support studies on metabolism, recovery, and body composition.

May 12, 2026

Science

Ipamorelin vs GHRP-2: Which Offers More Targeted GH Release?

Ipamorelin and GHRP-2 both stimulate growth hormone release via the ghrelin receptor, but Ipamorelin provides more selective action with minimal impact on other hormones like ACTH and cortisol. GHRP-2 delivers stronger GH pulses alongside broader endocrine effects. Combining them can enhance overall GH output through additive receptor stimulation.

May 12, 2026

Science

Ipamorelin: Selective GH Secretagogue for Clean Pulsatile Release

Ipamorelin, a third-generation GHS-R1a agonist (CAS 170851-70-4), stimulates pulsatile growth hormone release without elevating cortisol or prolactin, unlike earlier GHRPs. This selectivity supports precise research into GH axis effects, IGF-1 pathways, body composition, recovery, and sleep. Studies highlight its role in anabolic processes and synergy with CJC-1295 for enhanced GH output.

May 12, 2026